Literature DB >> 10930959

Re: 'Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir'.

D J Back1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930959      PMCID: PMC2014398          DOI: 10.1046/j.1365-2125.2000.00246.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir.

Authors:  V A Eagling; D J Back; M G Barry
Journal:  Br J Clin Pharmacol       Date:  1997-08       Impact factor: 4.335

2.  Pharmacokinetic interactions between sildenafil and saquinavir/ritonavir.

Authors:  G J Muirhead; M B Wulff; A Fielding; D Kleinermans; N Buss
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

3.  Indinavir concentrations and St John's wort.

Authors:  S C Piscitelli; A H Burstein; D Chaitt; R M Alfaro; J Falloon
Journal:  Lancet       Date:  2000-02-12       Impact factor: 79.321

4.  Interaction of sildenafil and indinavir when co-administered to HIV-positive patients.

Authors:  C Merry; M G Barry; M Ryan; J F Tjia; M Hennessy; V A Eagling; F Mulcahy; D J Back
Journal:  AIDS       Date:  1999-10-22       Impact factor: 4.177

Review 5.  Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection.

Authors:  M Barry; F Mulcahy; C Merry; S Gibbons; D Back
Journal:  Clin Pharmacokinet       Date:  1999-04       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.